Since semaglutide reduces appetite, many people inadvertently consume less dietary fiber and fluids
Typically mild and improves over 1-2 weeks at each dose level Constipation : Tirzepatide slows gastric emptying, which can reduce bowel movement frequency Diarrhea : Some patients experience the opposite problem, particularly at higher doses Headaches : Common in the first week or two, usually resolving on their own Fatigue : Especially during early treatment when caloric intake drops significantly Injection site reactions : Redness, itching, or mild swelling at the injection site Dry mouth : A less discussed but fairly common side effect Muscle pain : Some patients report muscle aches, particularly during dose escalation Anxiety : Less common but reported by some patients VitaStir reviewers consistently mention that side effects are manageable

A profoundly low number of severe food preoccupation episodes (and a reduction in body weight) during months 24 (excluding month 1 after surgery because of a potential implantation effect 27 ) was consistent with a concomitant increase in tirzepatide for diabetes management 11,28
This is a civilizational shift in which appetite control has become a productivity weapon, a dating market filter, a status accelerator, and a medical vulnerability